TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 46.7 +0.60 (+1.3%) Sep 14
19.93
P/B:
13.84
Market Cap:
€ 7.13B ($ 8.23B)
Enterprise V:
€ 7.30B ($ 8.43B)
Volume:
0
Avg Vol (2M):
154.00
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc